Forge Biologics

Forge Biologics Forge Biologics is a leading AAV gene therapy CDMO enabling access to life changing gene therapies and helping bring them from idea into reality.

What should developers be thinking about now when choosing a manufacturing partner? Our Vice President of Operations, As...
08/31/2026

What should developers be thinking about now when choosing a manufacturing partner?

Our Vice President of Operations, Ashley Craddick, is joining BioSpace's webinar, “Manufacturing in Turbulent Times: How Sponsors Can Future-Proof Partnerships and Avoid Costly Roadblocks.”

Ashley will join fellow industry experts to discuss navigating manufacturing challenges, avoiding process transfer and compliance gaps, and what to look for in a CDMO partner built for the long term.

🗓️ September 16
⏰ 1:00-2:00 PM ET
📍 Virtual: https://www.biospace.com/events/register-manufacturing-in-turbulent-times-how-sponsors-can-future-proof-partnerships-and-avoid-costly-roadblocks

08/28/2026

Which lab do you think uses these tools?

Watch until the end to see if you got it right!

08/27/2026

AAV has come a long way. In our first Bench Strength episode, David Dismuke, Ph.D., and Maritza McIntyre, Ph.D., took a walk to talk about it.

Starting on Forge’s Main Street, the two longtime colleagues look back at the early days of AAV, from working with cell stacks and plates to seeing the industrial scale possible today.

It’s a conversation about how far the field has come, the innovations that got us here and what’s still ahead.

🎧 Watch the first episode of Bench Strength now!

Our Chief Regulatory Officer, Christopher Shilling, is heading to Washington, D.C. for the American Society of Gene & Ce...
08/26/2026

Our Chief Regulatory Officer, Christopher Shilling, is heading to Washington, D.C. for the American Society of Gene & Cell Therapy Policy Summit on September 14, where he’ll moderate "Unpacking Expedited Program Flexibilities for CMC."

🗓️September 14
📍Washington D.C.
⏰ 4:00 PM

The Summit brings together industry leaders, scientists and policymakers for important conversations around the regulatory and policy landscape shaping cell and gene therapy.

We’re looking forward to being part of the conversation and connecting with colleagues across the field!

⛳️ Driving an impact inside and outside of the lab. Yesterday we were proud to participate in the Fore One Purpose golf ...
08/25/2026

⛳️ Driving an impact inside and outside of the lab.

Yesterday we were proud to participate in the Fore One Purpose golf tournament. This event brought together the Columbus gene therapy community to raise awareness for, and support families affected by ultra rare conditions.

At Forge, our work is driven by a shared mission to help our clients bring life-changing gene therapies to their patients, and days like this remind us why that work matters.

Kinda chic to hop on a trend. Even cooler to have this many reasons to do it.Here's all the ways Forge is kinda chic ⬇️
08/24/2026

Kinda chic to hop on a trend. Even cooler to have this many reasons to do it.

Here's all the ways Forge is kinda chic ⬇️

08/22/2026

🎉 Cheers to five incredible years!

Since 2021, She Forges, our employee women's resource group, has been recruiting, developing, and celebrating women across biotech. As we look back on the last five years, we're grateful for the community we've built at Forge, in Columbus, and worldwide. We're also thankful to our founding members for helping us start this incredible journey, and we're more excited than ever for what's ahead.

Swipe through for a look at what these five years have meant for the women of She Forges.

08/21/2026

Every gene therapy developer faces the same question early on: where should you focus today to avoid challenges as your program advances?

To help, we’ve narrowed it down to five key areas every developer should consider when building a strong manufacturing strategy. Take a look below and let us know which one you think should be number one!

08/20/2026

What are the first manufacturing decisions to think about?

It’s the kind of question we tackle in "Ask Dr. Barrett," our developer advice column where Brianna Barrett, Ph.D., answers real gene therapy developer questions with practical guidance shaped by supporting 60+ programs.

Watch her answer, then subscribe to Scaling Updates to read her column weekly! https://lnkd.in/eC55f3fP

08/18/2026

We’re hiring a Lead GMP Technician, Downstream (2nd Shift)

As a Lead GMP Technician you will take on a leadership role in our downstream GMP manufacturing operations. Part of your duties will include guiding and mentoring a team of technicians while supporting the purification of viral vectors for gene therapy programs in our state-of-the-art cleanroom facilities.

You’ll bring your downstream expertise to processes including TFF, column packing and testing, and affinity/anion exchange chromatography, while collaborating across Manufacturing, MS&T, Quality, and Technical Writing to support process transfers, troubleshoot challenges, and maintain cGMP compliance.

If you’re an experienced downstream manufacturing professional ready to lead a team and help bring life-changing gene therapies to those that need them most, this is the position for you.

Learn more and apply here: https://www.forgebiologics.com/careers/

Address

3900 Gantz Road
Grove City, OH
43123

Website

Alerts

Be the first to know and let us send you an email when Forge Biologics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Forge Biologics:

Shortcuts

Share

Category